{"filings":[{"id":128631,"accession_number":"0001193125-25-256604","cik":2029769,"company_name":"Oaktree Acquisition Corp. III Life Sciences","ticker":"OACC","form_type":"8-K","filed_at":"2025-10-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CFO Thomas Sweeney resigns; George Martinez appointed as new CFO at Oaktree Acquisition Corp. III Life Sciences","event_type":"leadership","confidence":"high","bullets":["Thomas Sweeney resigned as CFO effective Oct 29, 2025, to pursue other opportunities; no disagreement with Board or management.","Board appointed George A. Martinez as CFO effective immediately; Martinez is a Senior VP at Oaktree Capital Management, formerly Audit Senior Manager at EY.","Martinez will not receive compensation from the Company and has no employment agreement; he will enter into standard indemnity and letter agreements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":128630,"accession_number":"0001193125-25-242643","cik":2029769,"company_name":"Oaktree Acquisition Corp. III Life Sciences","ticker":"OACC","form_type":"8-K","filed_at":"2025-10-17T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as independent director","event_type":"leadership","confidence":"high","bullets":["Appointed Oct 17, 2025 as Class II director on audit, nominating, and compensation committees; deemed independent under Nasdaq and Rule 10A-3.","Co-founder & Managing Partner of Averin Capital (since May 2025); former Partner/GP at Flagship Pioneering (2005-2025); founder/CEO of Valo Health.","No cash compensation; eligible to invest non-controlling minority interest in Oaktree Acquisition Holdings III LS, consistent with other independent directors.","Will execute standard Letter Agreement and Indemnity Agreement on same terms as directors/officers from IPO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163795,"accession_number":"0001193125-25-137105","cik":2029769,"company_name":"Oaktree Acquisition Corp. III Life Sciences","ticker":"OACC","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Oaktree Acquisition Corp. III Life Sciences CFO resigns; Thomas Sweeney appointed CFO","event_type":"leadership","confidence":"high","bullets":["Courtney Conigliaro resigned as CFO effective June 3, 2025; resignation not due to any disagreements.","Board appointed Thomas Sweeney as CFO (principal accounting/financial officer) effective June 3, 2025.","Sweeney is a Managing Director at Oaktree Capital Management; will not receive compensation from the company.","Board confirmed Alvin Shih as chair of the audit committee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}